We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
AusPAR: Alirocumab
Australian Public Assessment Report
Device/Product Name
Praluent
Active ingredients
Alirocumab
AusPAR Date
Published
Sponsor
Submission Number
PM-2016-01950-1-3
Submission Type
Major variation: extension of indications and new dose regimen
Decision
Approved